← Leaderboards
Sheetal Hardikar
University Of Utah
$2,353,024
Attributed
$2,353,024
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $802.9K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,353,024 · 2
By mechanism
R01$1,562,259 · 1
K07$790,765 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Utah
Same institution · by research overlap
- Randall Walter Burt$9,014,360
- Alexander Tsodikov$9,962,904
- Prasoona Karra$335,411
- Janet Elizabeth Lainhart$14,533,256
- Andrew L Alexander$17,976,909
Others in their field
Other Emerging Leaders on “Cohort”
- Leonard Freedman · Leidos Biomedical Research, Inc.$70,225,348
- April Brinkoetter · Hungry Heart Media, Inc.$57,302,265
- Julie Ake · National Institute Of Allergy And Infectious Diseases$52,642,120
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- Scott Hensley · University Of Pennsylvania$47,346,110
- Susan M Landau · University Of California Berkeley$47,252,026
Research focus
CohortInflammationMortalityComorbidityColorectal CancerDiagnosisCost EffectiveMalignant NeoplasmsAwardColonoscopyColorectal AdenomaAdenomaColorectal Cancer ProgressionBaseClinical DiagnosisChronicCodeBiomedical InformaticsActive LearningChemopreventive AgentClinicCancer EpidemiologyAntidiabetic DrugsAccounting
Grant awards (7)
Geriatric assessment domains in relation to treatment outcomes among older adults with colorectal cancer$759,334
R01 · FY2025 · AG · contact PI
Geriatric assessment domains in relation to treatment outcomes among older adults with colorectal cancer$802,925
R01 · FY2024 · AG · contact PI
Diabetes, Medications and the Cost-Effectiveness of Screening for Colorectal Neoplasia$158,153
K07 · FY2022 · CA · contact PI
Diabetes, Medications and the Cost-Effectiveness of Screening for Colorectal Neoplasia$158,153
K07 · FY2021 · CA · contact PI
Diabetes, Medications and the Cost-Effectiveness of Screening for Colorectal Neoplasia$158,153
K07 · FY2020 · CA · contact PI
Diabetes, Medications and the Cost-Effectiveness of Screening for Colorectal Neoplasia$158,153
K07 · FY2019 · CA · contact PI
Diabetes, Medications and the Cost-Effectiveness of Screening for Colorectal Neoplasia$158,153
K07 · FY2018 · CA · contact PI